Device-Related Thrombus: A Reason for Concern?
References
- Colilla S Crow A Petkun W Singer DE Simon T Liu X Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population Am J Cardiol 2013 Oct 15 112 8 1142 7
- Benjamin EJ Blaha MJ Chiuve SE .; American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association Circulation 2017 Mar 7 135 10 e146 e603
- Chugh SS Havmoeller R Narayanan K Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study Circulation 2014 Feb 25 129 8 837 47
- Marijon E Le Heuzey JY Connolly S .; RE-LY Investigators Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study Circulation 2013 Nov 12 128 20 2192 201
- Wolf PA Abbott RD Kannel WB Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 1991 Aug 22 8 983 8
- January CT Wann LS Alpert JS .; ACC/AHA Task Force Members 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society Circulation 2014 Dec 2 130 23 2071 104
- Friberg L Rosenqvist M Lip GY Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study Eur Heart J 2012 Jun 33 12 1500 10
- Connolly SJ Ezekowitz MD Yusuf S .; RE-LY Steering Committee and Investigators Dabigatran versus warfarin in patients with atrial fibrillation New Engl J Med 2009 Sep 17 361 12 1139 51
- Granger CB Alexander JH McMurray JJ .; ARISTOTLE Committees and Investigators Apixaban versus warfarin in patients with atrial fibrillation New Engl J Med 2011 Sep 15 365 11 981 92
- Patel MR Mahaffrey KW Garg J .; ROCKET AF Investigators Rivaroxaban versus warfarin in nonvalvular atrial fibrillation New Engl J Med 2011 Sep 8 365 10 883 91
- Gage BF Yan Y Milligan PE Clinical classification schemes for predicting hemorrhage:results from the National Registry of Atrial Fibrillation (NRAF) Am Heart J 2006 Mar 151 3 713 9
- Pisters R Lane DA Nieuwlaat R de Vos CB Crijns HJ Lip GY A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey Chest 2010 Nov 138 5 1093 100
- Singer DE Chang Y Borowsky LH A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score J Am Heart Assoc 2013 Jun 21 2 3 e000250
- Blackshear JL Odell JA Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation Ann Thorac Surg 1996 Feb 61 2 755 9
- Holmes DR Doshi SK Kar S Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation J Am Coll Cardiol 2015 Jun 23 65 24 2614 23
- Shamim S Magalski A Chhatriwalla AK Allen KB Huber KC Main ML Transesophageal echocardiographic diagnosis of a WATCHMAN left atrial appendage closure device thrombus 10 years following implantation Echocardiography 2017 Jan 34 1 128 130
- Reddy VY Holmes D Doshi SK Neuzil P Kar S Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry Circulation 2011 Feb 1 123 4 417 24
- Kubo S Mizutani Y Meemook K Nakajima Y Hussaini A Kar S Incidence, Characteristics, and Clinical Course of Device-Related Thrombus After Watchman Left Atrial Appendage Occlusion Device Implantation in Atrial Fibrillation Patients JACC Clin Electrophysiol 2017 Dec 11 3 12 1380 6
- Boersma LV Ince H Kische S .; EWOLUTION Investigators Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial Heart Rhythm 2017 Sep 14 9 1302 8
- Enomoto Y Gadiyaram VK Gianni C Use of non-warfarin oral anticoagulants instead of warfarin during left atrial appendage closure with the Watchman device Heart Rhythm 2017 Jan 14 1 19 24
- Massarenti L Yilmaz A Incomplete endothelialization of left atrial appendage occlusion device 10 months after implantation J Cardiovasc Electrophysiol 2012 Dec 23 12 1384 5
DOI: https://doi.org/10.14797/mdcj-15-1-77 | Journal eISSN: 1947-6108
Language: English
Page range: 77 - 80
Published on: Jan 1, 2019
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2019 Bashar Hannawi, Faheemullah Beg, Miguel Valderrábano, Karla Kurrelmeyer, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.